Dr Ansgar Santel joined our Berlin office as Technology Development Manager in November 2017. He brings 15 years’ experience in the international biotech industry to the team, and in particular his expertise and enthusiasm for the translational development of innovative therapies. As Senior Scientist Translational & Clinical Research in a German-English biotech company, he advanced a novel RNAi-therapy from its conception through to clinical testing. A further focus of his work was the initiation and management of research alliances between industry and academia. Together with his colleagues at Ascenion, he will use this experience to effectively support scientists at Ascenion’s partner institutes during the application-oriented development of their research projects.
Ansgar studied biology at the Phillips-Universität, Marburg, Germany, where he also gained a PhD in molecular biology, before spending four years as a postdoctoral fellow at the Stanford University School of Medicine, Palo Alto, USA.